<h3>涨幅股</h3>
<ul>
<li><strong>PACS Group</strong> (NYSE: PACS) 股票在周二的盘前交易中上涨了 17.6%，达到 37.5 美元。该公司的市值为 50 亿美元。根据新闻稿，第一季度的财报昨天发布。</li>
<li><strong>Akari Therapeutics</strong> (NASDAQ: AKTX) 股票上涨了 16.31%，达到 5.99 美元。该公司的市值为 1.84 亿美元。</li>
<li><strong>Macrogenics</strong> (NASDAQ: MGNX) 股票上涨了 16.27%，达到 3.43 美元。其流通股的市场价值为 1.874 亿美元。</li>
<li><strong>USBC</strong> (AMEX: USBC) 股票上涨了 12.69%，达到 0.57 美元。其流通股的市场价值为 1.971 亿美元。</li>
<li><strong>Phio Pharmaceuticals</strong> (NASDAQ: PHIO) 股票上涨了 10.18%，达到 1.19 美元。其流通股的市场价值为 1250 万美元。根据新闻稿，第一季度的财报在 3 天前发布。</li>
<li><strong>Dyadic International</strong> (NASDAQ: DYAI) 股票上涨了 9.08%，达到 0.79 美元。该公司的市值为 2630 万美元。</li>
</ul>
<h3>跌幅股</h3>
<ul>
<li><strong>WORK Medical Tech Gr</strong> (NASDAQ: WOK) 股票在周二的盘前交易中下跌了 45.7%，达到 2.13 美元。</li>
<li><strong>CEL-SCI</strong> (AMEX: CVM) 股票下跌了 26.25%，达到 1.04 美元。该公司的市值为 1190 万美元。</li>
<li><strong>Pomdoctor</strong> (NASDAQ: POM) 股票下跌了 22.69%，达到 0.11 美元。其流通股的市场价值为 1760 万美元。</li>
<li><strong>China Pharma Holding</strong> (AMEX: CPHI) 股票下跌了 21.78%，达到 0.42 美元。该公司的市值为 260 万美元。</li>
<li><strong>Organigram Global</strong> (NASDAQ: OGI) 股票下跌了 16.02%，达到 1.1 美元。其流通股的市场价值为 1.842 亿美元。根据新闻，第二季度的财报今天发布。</li>
<li><strong>Ensysce Biosciences</strong> (NASDAQ: ENSC) 股票下跌了 14.88%，达到 0.33 美元。其流通股的市场价值为 350 万美元。
<strong>另见：</strong> www.benzinga.com/money/best-healthcare-stocks/</li>
</ul>
<p>本文由 Benzinga 的自动内容引擎生成，并由编辑审核。</p>

MGNX

USBC

<p>在周二的盘前交易中，PACS Group 录得显著上涨，涨幅达到 17.6%，股价达到 37.5 美元，市值为 50 亿美元。其他 notable 的涨幅股票包括 Akari Therapeutics (+16.31%)、Macrogenics (+16.27%) 和 USBC (+12.69%)。相反，WORK Medical Tech 经历了 45.7% 的急剧下跌，其后是 CEL-SCI (-26.25%) 和 Pomdoctor (-22.69%)。总体而言，本次交易突显了医疗保健股票的重大波动，受到近期财报的影响</p>

<h3>Gainers</h3>
<div class="lb-trans"><h3>涨幅股</h3>
</div><ul>
<li><strong>PACS Group</strong> (NYSE: PACS) stock rose 17.6% to $37.5 during Tuesday's pre-market session. The company's market cap stands at $5.0 billion. As per the press release, Q1 earnings came out yesterday.</li>
<li><strong>Akari Therapeutics</strong> (NASDAQ: AKTX) shares moved upwards by 16.31% to $5.99. The company's market cap stands at $184.0 million.</li>
<li><strong>Macrogenics</strong> (NASDAQ: MGNX) stock increased by 16.27% to $3.43. The market value of their outstanding shares is at $187.4 million.</li>
<li><strong>USBC</strong> (AMEX: USBC) stock increased by 12.69% to $0.57. The market value of their outstanding shares is at $197.1 million.</li>
<li><strong>Phio Pharmaceuticals</strong> (NASDAQ: PHIO) shares rose 10.18% to $1.19. The market value of their outstanding shares is at $12.5 million. As per the press release, Q1 earnings came out 3 days ago.</li>
<li><strong>Dyadic International</strong> (NASDAQ: DYAI) stock rose 9.08% to $0.79. The company's market cap stands at $26.3 million.</li>
</ul>
<div class="lb-trans"><ul>
<li><strong>PACS Group</strong> (NYSE: PACS) 股票在周二的盘前交易中上涨了 17.6%，达到 37.5 美元。该公司的市值为 50 亿美元。根据新闻稿，第一季度的财报昨天发布。</li>
<li><strong>Akari Therapeutics</strong> (NASDAQ: AKTX) 股票上涨了 16.31%，达到 5.99 美元。该公司的市值为 1.84 亿美元。</li>
<li><strong>Macrogenics</strong> (NASDAQ: MGNX) 股票上涨了 16.27%，达到 3.43 美元。其流通股的市场价值为 1.874 亿美元。</li>
<li><strong>USBC</strong> (AMEX: USBC) 股票上涨了 12.69%，达到 0.57 美元。其流通股的市场价值为 1.971 亿美元。</li>
<li><strong>Phio Pharmaceuticals</strong> (NASDAQ: PHIO) 股票上涨了 10.18%，达到 1.19 美元。其流通股的市场价值为 1250 万美元。根据新闻稿，第一季度的财报在 3 天前发布。</li>
<li><strong>Dyadic International</strong> (NASDAQ: DYAI) 股票上涨了 9.08%，达到 0.79 美元。该公司的市值为 2630 万美元。</li>
</ul>
</div><h3>Losers</h3>
<div class="lb-trans"><h3>跌幅股</h3>
</div><ul>
<li><strong>WORK Medical Tech Gr</strong> (NASDAQ: WOK) shares decreased by 45.7% to $2.13 during Tuesday's pre-market session.</li>
<li><strong>CEL-SCI</strong> (AMEX: CVM) stock decreased by 26.25% to $1.04. The company's market cap stands at $11.9 million.</li>
<li><strong>Pomdoctor</strong> (NASDAQ: POM) stock decreased by 22.69% to $0.11. The market value of their outstanding shares is at $17.6 million.</li>
<li><strong>China Pharma Holding</strong> (AMEX: CPHI) shares decreased by 21.78% to $0.42. The company's market cap stands at $2.6 million.</li>
<li><strong>Organigram Global</strong> (NASDAQ: OGI) shares fell 16.02% to $1.1. The market value of their outstanding shares is at $184.2 million. As per the news, the Q2 earnings report came out today.</li>
<li><strong>Ensysce Biosciences</strong> (NASDAQ: ENSC) shares decreased by 14.88% to $0.33. The market value of their outstanding shares is at $3.5 million.
<strong>See Also:</strong> www.benzinga.com/money/best-healthcare-stocks/</li>
</ul>
<div class="lb-trans"><ul>
<li><strong>WORK Medical Tech Gr</strong> (NASDAQ: WOK) 股票在周二的盘前交易中下跌了 45.7%，达到 2.13 美元。</li>
<li><strong>CEL-SCI</strong> (AMEX: CVM) 股票下跌了 26.25%，达到 1.04 美元。该公司的市值为 1190 万美元。</li>
<li><strong>Pomdoctor</strong> (NASDAQ: POM) 股票下跌了 22.69%，达到 0.11 美元。其流通股的市场价值为 1760 万美元。</li>
<li><strong>China Pharma Holding</strong> (AMEX: CPHI) 股票下跌了 21.78%，达到 0.42 美元。该公司的市值为 260 万美元。</li>
<li><strong>Organigram Global</strong> (NASDAQ: OGI) 股票下跌了 16.02%，达到 1.1 美元。其流通股的市场价值为 1.842 亿美元。根据新闻，第二季度的财报今天发布。</li>
<li><strong>Ensysce Biosciences</strong> (NASDAQ: ENSC) 股票下跌了 14.88%，达到 0.33 美元。其流通股的市场价值为 350 万美元。
<strong>另见：</strong> www.benzinga.com/money/best-healthcare-stocks/</li>
</ul>
</div><p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>
<div class="lb-trans"><p>本文由 Benzinga 的自动内容引擎生成，并由编辑审核。</p>
</div>

12 只医疗保健股票在周二盘前交易时段的变动情况